Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation - Université Claude Bernard Lyon 1 Accéder directement au contenu
Article Dans Une Revue Blood Année : 2020

Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Mohamad Mohty
Myriam Labopin
Charlotte Jubert
  • Fonction : Auteur

Dates et versions

hal-03606392 , version 1 (11-03-2022)

Identifiants

Citer

Mohamad Mohty, Ibrahim Yakoub-Agha, Myriam Labopin, Didier Blaise, Delphine Lebon, et al.. Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Blood, 2020, 136 (1), ⟨10.1182/blood-2020-136685⟩. ⟨hal-03606392⟩
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More